Clinical Trial Update: A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating short-term preoperative activity and safety of elacestrant as monotherapy versus elacestrant with an LHRH agonist in premenopa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Elacestrant (elacestrant)
• LHRH agonist (Gonadotropin-releasing hormone (GnRH) agonist)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING